CRC for Cancer Therapeutics
Part of the Industry and Science portfolio and a Federal authority
The major challenge for the CRC for Cancer Therapeutics (CTx) is to address the leading single cause of death in Australia – cancer. CTx discovers, protects and develops small molecules into pre-clinical drug candidates with high commercial potential. These candidates are chosen for their ability to better target cancer cells rather than normal healthy cells, to improve clinical outcomes and produce large healthcare system efficiencies. Please note: This authority is not technically subject to FOI, but you can still make requests to it
Freedom of Information requests made using this site
Nobody has made any Freedom of Information requests to CRC for Cancer Therapeutics using this site yet.
More about this authorityHome page of authority
View FOI email address
Ask us to update FOI email